Acumen Pharmaceuticals, Inc. Operating Lease Liability
Acumen Pharmaceuticals, Inc. (ABOS) had Operating Lease Liability of $77.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability $77.00K.
- 2026-03-31: Operating Lease, Liability $114.00K.
- 2025-12-31: Operating Lease, Liability $150.00K.
- 2025-09-30: Operating Lease, Liability $185.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $77.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $114.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $150.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $185.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $219.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $252.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $283.00K 10-K · filed 2026-03-26 | |
| 2023-12-31 | $394.00K 10-K · filed 2025-03-27 | $393.00K 10-K · filed 2024-03-26 |
| 2022-12-31 | $105.00K 10-K · filed 2023-03-27 | |
| 2022-09-30 | $133.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $167.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $201.00K 10-Q · filed 2022-05-16 | |
| 2022-01-01 | $200.00K 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |